New Pilot Study Validates Daxor's Blood Volume Analysis for COVID and Sepsis Patients, Highlighting Urgent Need for Accurate Fluid Management Tools in Critical Care.

A new pilot study published in the Journal of Critical Care has found that clinicians frequently misdiagnose fluid levels in critically ill patients with sepsis and COVID-19, highlighting the need for more reliable tools like Daxor's Blood Volume Analysis. The study found that patients were often mistakenly believed to be fluid overloaded when they were actually fluid deficient, and vice-versa. Daxor's CEO notes that accurate blood volume measurement is essential in critical care, especially for conditions like sepsis that require individualized fluid management.